FNDC5 and Alzheimer disease: Given that the enhancement of neurogenesis could potentially improve the impaired synaptic plasticity and memory dysfunction found in AD [26,28,29], irisin may be a potential therapeutic target for AD as it promotes both neurogenesis and neuronal cell survival.